GlassScriptPhysician profile
Marty L Allison
NPI 1013981927
$1,691.09
in general payments reported to CMS, 2019-2025
20 companies · $158 in 2025
The $158 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $500 · 2020: $104 · 2022: $230 · 2023: $417 · 2024: $283 · 2025: $158.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $857.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $856.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $380.16 | 2019-2025 | Evenity, Prolia, Repatha |
| Novo Nordisk INC | $350.27 | 2019-2024 | Rybelsus, Ozempic |
| Merck Sharp & Dohme LLC | $192.19 | 2019-2025 | Capvaxive, Vaxneuvance, Gardasil 9 |
| E.R. Squibb & Sons, L.L.C. | $164.10 | 2023-2025 | Eliquis, Camzyos |
| Daiichi Sankyo INC. | $121.77 | 2022-2024 | Injectafer |
| Bayer Healthcare Pharmaceuticals INC. | $76.71 | 2022-2024 | |
| Pfizer INC. | $52.88 | 2019-2024 | |
| Lilly USA, LLC | $49.99 | 2022-2023 | Mounjaro, Trulicity |
| Biohaven Pharmaceutical Holding Company LTD. | $43.39 | 2022 | |
| Medtronic, INC. | $41.52 | 2022-2024 | Minimed 780g |
| Philips North America LLC | $37.99 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $33.40 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $28.31 | 2023 | Farxiga |
| Janssen Pharmaceuticals, INC | $24.73 | 2022-2023 | Xarelto |
| Glaxosmithkline, LLC. | $19.35 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $18.52 | 2023 | Veozah |
| Exact Sciences Corporation | $15.88 | 2025 | The Cologuard Plus Collection Kit |
| Vertex Pharmaceuticals Incorporated | $13.85 | 2024 | |
| Solventum Corporation | $13.58 | 2024 | Prevena, V.A.C. Dermatac, V.A.C.Ulta |
| Novartis Pharmaceuticals Corporation | $12.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marty Allison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.